{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:51:40Z","timestamp":1761173500804,"version":"build-2065373602"},"reference-count":15,"publisher":"Gobierno de Navarra","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An Sist Sanit Navar"],"published-print":{"date-parts":[[2009,9,23]]},"DOI":"10.23938\/assn.0609","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T03:28:36Z","timestamp":1557286116000},"page":"175-181","source":"Crossref","is-referenced-by-count":0,"title":["Administering toxins with antithyroids. Does this prevent recidivism of Graves disease?"],"prefix":"10.23938","volume":"20","member":"10024","reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1056\/NEJM199601253340412","article-title":"Inmunosupression of Graves' hyperthyroidism - still an elusive goal","volume":"334","author":"WiErsINGA","year":"1996","unstructured":"1. WiErsINGA WM. Inmunosupression of Graves' hyperthyroidism - still an elusive goal. New Engl J Med 1996; 334:265-266.","journal-title":"New Engl J Med"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJM199406163302407","article-title":"The management of hyperthyroidism","volume":"330","author":"FrankiyN","year":"1994","unstructured":"2.FrankiyN JA. The management of hyperthyroidism. New Engl J Med 1994; 330: 1731-1738.","journal-title":"New Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1210\/jcem-70-3-675","article-title":"Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration","volume":"70","author":"ALLannic","year":"1990","unstructured":"3.ALLannic H, FaucHer R, ORclazzi J et al. Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration. J Clin Endocrinol Metab 1990; 70: 675-679.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/bmj.4.5885.143","article-title":"Single-dose, \"Block-Replace\" drug therapy in hyperthyroidism","volume":"4","author":"WisE","year":"1973","unstructured":"4. WisE PH, MArRiON M, Pain RW. Single-dose, \"Block-Replace\" drug therapy in hyperthyroidism. Br Med J 1973; 4: 143-145.","journal-title":"Br Med J"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1210\/jcem-57-3-563","article-title":"Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism","volume":"57","author":"RomaLDINI","year":"1983","unstructured":"5.RomaLDINI JH, BROMBERG N, WERNER RS et al. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism. J Clin Endocrinol Metab 1983; 57: 563-570.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","unstructured":"6.Duprey J, Louils MF, DUCORNET B et al Am\u00e9lioration du pronostic de la maladie de Basedow par utilisation de fortes doses de carbimazole. Presse M\u00e9d 1988; 17: 1124-1127."},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7.REINWEIN D, BENKER G, LazArRUS JH, ALEXANDER WD. The European Multicenter Study Group on Antithyroid Drug Treatment. J Clin Endocrinol Metab 1993; 76: 1516-1521.","DOI":"10.1210\/jcem.76.6.8501160"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Tamal H, Havaki I, Kawal K et al. Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients. J Clin Endocrinol Metab 1995; 80: 1481-1484.","DOI":"10.1210\/jc.80.5.1481"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJM199104043241403","article-title":"Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism","volume":"324","author":"HasHizuME","year":"1991","unstructured":"9.HasHizuME K, IcHikawa K, Sakural A et al. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. New Engl J Med 1991; 324:947-953.","journal-title":"New Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1056\/NEJM199601253340403","article-title":"Lack of effect of thyroxine in patients with Graves'hyperthyroidism who are treated with an antithyroid drug","volume":"334","author":"Mclver","year":"1996","unstructured":"10. Mclver B, RAE P, BECKETT G et al. Lack of effect of thyroxine in patients with Graves'hyperthyroidism who are treated with an antithyroid drug. New Engl J Med 1996; 334: 220-224.","journal-title":"New Engl J Med"},{"key":"ref10","unstructured":"11.Vorpt R. Autoinmune thyroid disease. A perspective. Mol Biol Med 1986; 3: 25-51."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1365-2265.1984.tb03456.x","article-title":"WEETMAN, AP, MCGREGOR AM, HaLL R, Evidence for an effect of antithyroid drugs on the natural history of Graves' disease","volume":"21","author":"12","year":"1984","unstructured":"12. WEETMAN, AP, MCGREGOR AM, HaLL R, Evidence for an effect of antithyroid drugs on the natural history of Graves' disease. Clin Endocrinol 1984; 21: 163-172.","journal-title":"Clin Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1210\/endo-112-1-326","article-title":"The influence of methimazole on thyroglobulininduced autoinmune thyroiditis in the rat","volume":"112","author":"RenniE","year":"1983","unstructured":"13. RenniE DP, MCGREGOR AM, KEasT D et al. The influence of methimazole on thyroglobulininduced autoinmune thyroiditis in the rat. Endocrinology 1983; 112: 326-330.","journal-title":"Endocrinology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1056\/NEJM198008073030603","article-title":"Carbimazole and the autoinmune response in Graves' disease","volume":"303","author":"McGREGOR","year":"1980","unstructured":"14. McGREGOR AM, PETERSEN MM, McLACHLAN SM et al. Carbimazole and the autoinmune response in Graves' disease. New Engl J Med 1980; 303: 302-307.","journal-title":"New Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. SwansoN Beck J, Younc RJ, SimMpsoN JG et al. Lymphoid tissue in the thyroid gland and thymus of patients with primary thyrotoxicosis. Br J Surg 1973: 60: 769-771.","DOI":"10.1002\/bjs.1800601005"}],"container-title":["Anales del Sistema Sanitario de Navarra"],"original-title":[],"link":[{"URL":"https:\/\/recyt.fecyt.es\/index.php\/ASSN\/article\/view\/7455\/9258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:23:43Z","timestamp":1761114223000},"score":1,"resource":{"primary":{"URL":"https:\/\/recyt.fecyt.es\/\/index.php\/ASSN\/article\/view\/7455\/9258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,23]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,9]]}},"URL":"https:\/\/doi.org\/10.23938\/assn.0609","relation":{},"ISSN":["1137-6627"],"issn-type":[{"type":"print","value":"1137-6627"}],"subject":[],"published":{"date-parts":[[2009,9,23]]}}}